| |
| |
|
| Insider
Information: |
Goddard Glenn |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
69,213 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,814,765 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
69,213 |
|
|
| Total
Value |
$1,814,765 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -63.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Agios Pharmaceuticals Inc |
AGIO |
Senior Vice President,... |
2015-09-24 |
0 |
2014-01-21 |
0 |
Premium* |
|
|
Intellia Therapeutics, Inc. |
NTLA |
|
2024-03-01 |
69,213 |
2021-08-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
61 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGIO |
Agios Pharmaceuticals Inc |
Senior Vice President, Finance |
• – – |
2014-01-21 |
4 |
AS |
$34.71 |
$347,108 |
D/D |
(10,000) |
0 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Senior Vice President, Finance |
• – – |
2014-01-27 |
4 |
AS |
$26.29 |
$184,051 |
D/D |
(7,000) |
0 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Senior Vice President, Finance |
• – – |
2014-02-10 |
4 |
AS |
$30.44 |
$182,640 |
D/D |
(6,000) |
0 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Senior Vice President, Finance |
• – – |
2014-02-18 |
4 |
AS |
$35.06 |
$123,832 |
D/D |
(3,532) |
0 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Senior Vice President, Finance |
• – – |
2014-03-06 |
4 |
AS |
$35.54 |
$194,333 |
D/D |
(5,468) |
0 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Senior Vice President, Finance |
• – – |
2014-03-07 |
4 |
AS |
$45.10 |
$541,200 |
D/D |
(12,000) |
0 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Senior Vice President, Finance |
• – – |
2014-04-01 |
4 |
AS |
$38.08 |
$152,320 |
D/D |
(4,000) |
0 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Senior Vice President, Finance |
• – – |
2014-04-07 |
4 |
AS |
$45.17 |
$90,340 |
D/D |
(2,000) |
0 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Senior Vice President, Finance |
• – – |
2014-05-01 |
4 |
AS |
$42.39 |
$84,780 |
D/D |
(2,000) |
0 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Senior Vice President, Finance |
• – – |
2014-07-01 |
4 |
AS |
$46.52 |
$162,820 |
D/D |
(3,500) |
0 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Senior Vice President, Finance |
• – – |
2014-09-02 |
4 |
AS |
$46.30 |
$463,000 |
D/D |
(10,000) |
0 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Senior Vice President, Finance |
• – – |
2014-09-26 |
4 |
AS |
$56.53 |
$989,275 |
D/D |
(17,500) |
0 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Senior Vice President, Finance |
• – – |
2014-10-01 |
4 |
AS |
$60.07 |
$90,105 |
D/D |
(1,500) |
0 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Senior Vice President, Finance |
• – – |
2014-11-03 |
4 |
AS |
$81.71 |
$163,420 |
D/D |
(2,000) |
0 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Senior Vice President, Finance |
• – – |
2015-02-09 |
4 |
AS |
$105.81 |
$1,587,150 |
D/D |
(15,000) |
0 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Senior Vice President, Finance |
• – – |
2015-02-11 |
4 |
AS |
$120.14 |
$181,772 |
D/D |
(1,513) |
0 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Senior Vice President, Finance |
• – – |
2015-02-13 |
4 |
AS |
$120.31 |
$158,328 |
D/D |
(1,316) |
0 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Senior Vice President, Finance |
• – – |
2015-03-16 |
4 |
AS |
$106.24 |
$1,062,400 |
D/D |
(10,000) |
0 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Senior Vice President, Finance |
• – – |
2015-05-27 |
4 |
AS |
$120.05 |
$260,629 |
D/D |
(2,171) |
0 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Senior Vice President, Finance |
• – – |
2015-07-17 |
4 |
AS |
$113.71 |
$1,478,230 |
D/D |
(13,000) |
0 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Senior Vice President, Finance |
• – – |
2015-07-23 |
4 |
AS |
$120.45 |
$843,150 |
D/D |
(7,000) |
0 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Senior Vice President, Finance |
• – – |
2015-09-24 |
4 |
AS |
$85.97 |
$515,820 |
D/D |
(6,000) |
0 |
0 |
- |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, Chief Financial Officer |
• – – |
2021-08-05 |
4 |
AS |
$150.65 |
$3,021,056 |
D/D |
(20,000) |
0 |
0 |
% |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, Chief Financial Officer |
• – – |
2021-08-30 |
4 |
AS |
$153.22 |
$810,082 |
D/D |
(5,200) |
0 |
0 |
% |
|
| NTLA |
Intellia Therapeutics, In... |
EVP, Chief Financial Officer |
• – – |
2021-08-31 |
4 |
AS |
$160.22 |
$3,973,456 |
D/D |
(24,800) |
0 |
0 |
% |
|
61 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
